Top 4 NYSE Stocks In The Drug Delivery Industry With The Highest Revenue (HSP, VRX, ELN, KV-A)

Below are the top drug delivery stocks on the NYSE in terms of revenue. The trailing-twelve-month revenue at Hospira Inc HSP is $3.92 billion. HSP's ROE for the same period is 12.30%. The trailing-twelve-month revenue at Valeant Pharmceutical International Inc VRX is $1.18 billion. VRX's operating margin for the same period is 22.36%. The trailing-twelve-month revenue at Elan Corporation plc ELN is $842.70 million. ELN's PEG ratio is 0.46. The trailing-twelve-month revenue at K-V Pharmaceutical Company KV is $149.35 million. KV-A had $25.66 million in total cash for the recent quarter. Trading Ideas.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MarketsTrading IdeasDrug Delivery IndustryHealth CareHealth Care EquipmentHighest RevenueNYSEPharmaceuticals
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!